IMS Health UK Market Access Summit 2015

29th June 2015

IMS Health UK Market Access Summit 2015

18.12 BST And with that Angela McFarlane brings things to a close with a brief summary and some recommendations - increased transparency of process and mandates of roles for the NHS, for the... Read more

Can new comms technology help HIV prevention and care?

29th June 2015

Can new comms technology help HIV prevention and care?David Rowlands

Globally, though overall rates of HIV are declining, those among gay men, men who have sex with men (MSM) and the transgender community are increasing. David Rowlands asks whether innovative... Read more

Best practice in health outcomes research

26th June 2015

Best practice in health outcomes research Nicola Bonner

Nicola Bonner clarifies the guidelines, and which are relevant, to ensure practitioners maintain high and consistent standards.Qualitative and quantitative non-interventional health outcomes research studies are on the increase, but there... Read more

The shape of market access in pharma: meeting stakeholders’ value need…

25th June 2015

The shape of market access in pharma: meeting stakeholders’ value needsJenny Hone

Brand success requires pharma companies to identify and meet the needs of all those involved and communicate where the clinical and economic values lie.Market access planning is a key challenge... Read more


Rare disease drugs lead CHMP approvals

29th June 2015

Rare disease drugs lead CHMP approvalsStaff reporter

The latest crop of position opinions from the EU's Committee for Medicinal Products for Human Use (CHMP) includes two drugs for rare diseases and two cancer therapies.The rare disease therapies... Read more

US Supreme Court secures Obamacare - for now

26th June 2015

US Supreme Court secures Obamacare - for nowStaff reporter

An attempt to do away with President Obama's signature Affordable Care Act has been defeated in the US Supreme Court in a 6 to 3 vote.If defeated, the dissolution of... Read more

London considers £10bn 'megafund' to boost drug development

25th June 2015

London considers £10bn 'megafund' to boost drug development

The Mayor of London Boris Johnson wants to make the city a world leader in life sciences, and aims to exploit financial expertise to boost investment in pharma and biotech.Among... Read more

NICE says new cancer guidance for GPs will save lives

24th June 2015

NICE says new cancer guidance for GPs will save livesStaff reporter

New guidance from the National Institute of Health and Care Excellence (NICE) means that patients suspected of having cancer will be referred much more quickly to specialist care.While GPs previously... Read more

Audio & Video

Live webinar 9th July – Changing behavio…

BrightTALK holding slide 4 22June


Understanding your customers is fundamental to effective communication. Current segmentation strategies draw on ever more detailed information... View more

Live webinar 1st July – Effectively usin…



Life sciences companies need to make better use of the insights that real world data (RWD) can provide in order to improve... View more

Available on demand: Exclusive debate/we…



The way that physicians want and need to consume information has changed dramatically over recent years and continues to evolve rapidly. Working in... View more

Being Patient-centric is being Family-ce…


Cancer survivor and patient opinion leader Andrew Schorr and his wife Esther Schorr discuss how families should be involved in decision-making around care for patients.... View more

White Papers

Optimising patient outcomes through phys…

Optimising patient outcomes through physician educationDr James Quekett

Physician education is undergoing a massive change as the volume of advances in therapies and practices increases and the use of digital channels facilitates new forms of scientific exchange. This white... View info

Is pharma brand marketing dead?

Is pharma brand marketing dead?Mark Sales, Fabrice Bourg & Richard Goosey

This comprehensive supplement brings together a series of articles, insights and discussions produced by Kantar Health in order to help stimulate debate and fresh thinking about the future of pharmaceutical... View info

Improved health and wellbeing in COPD

Improved health and wellbeing in COPDAna Maria Arboleda, Clare Maloney & Prof John Weinman

Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating disorder, which, as it progresses, places a significant burden on individuals and those caring for them. This is not only... View info

Computer Gaming: The Future of Decision-…

Computer Gaming: The Future of Decision-Making for Life Sciences?

How can life science brands identify winning strategic decisions when there are so many variables to consider? One route is via 'road-testing' decisions ahead of sign-off under computer game simulated... View info

Further News & Articles

Opdivo first PD-1 treatment to gain European approval

Bristol-Myers Squibb (BMS) has scored a victory over its rival Merck by gaining the first European approval in t... Read more


UK first to offer routine meningitis B vaccination

All babies in England and Scotland will be offered meningitis B (MenB) vaccines from September, as disputes over... Read more


UK pharma disclosure of payments: lessons from the US Sunshine Act

In the second article on pharma's disclosure of payments in the UK, Andrew McConaghie talks to the PMCPA's Heathe... Read more


NICE asks for more information on Gilead's Zydelig

The National Institute for Health and Care Excellence (NICE) has rejected Gilead Sciences' chronic lymphocytic l... Read more


Oncology opinion leaders debate NHS issues

Medical, political and patient organisation specialists were put through their paces on topics affecting delivery... Read more


Novartis to highlight ageing research at US investor day

Novartis will describe to investors later today how it is developing a series of therapies for diseases of old a... Read more